Recurrent IgA nephropathy in transplant

Recent Advances in IgA Nephropathy

Volumn , Issue , 2009, Pages 149-159

  Choy, Bo Ying ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958761165     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812835871_0011     Document Type: Chapter

References (30)

1. Berger J, Yaneva H, Nabarra B, Barbanel C. (1975) Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 7: 232-241.
2. Choy BY, Chan TM, Lai KN. (2006) Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 6: 2535-2542.
3. Coppo R, Amore A, Chiesa M, et al. (2007) Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation. Clin Transplant 21(6): 728-737.
4. Moriyama T, Nitta K, Suzuki K, et al. (2005) Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Clin Transplant 19(Suppl 14): 41-48.
5. Choy BY, Chan TM, Lo SK, et al. (2003) Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 18: 2399-2404.
6. BrIgAnti EM, Russ GR, McNeil JJ, et al. (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347: 103-109.
7. Andresdottir MB, Hoitsma AJ, Assmann KJ, et al. (2001) Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 56: 279-288.
8. Ponticelli C, Traversi L, Feliciani A, et al. (2001) Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 60: 1948-1954.
9. Wang AYM, Lai FM, Yu AWY, et al. (2001) Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 38: 588-596.
10. Kim YS, Moon JI, Jeong HJ, et al. (2001) Live donor renal allograft in end- stage renal failure patients from immunoglobulin A nephropathy. Transplantation 71: 233-238.
11. Freese P Svalander C, Norden G, et al. (1999) Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 13: 313-317.
12. Bumgardner GL, Amend WC, Ascher WL, et al. (1998) Single centre long term results of renal transplantation for IgA nephropathy. Transplantation 65: 1053-1060.
13. Ohmacht C, Kliem V Burg M, et al. (1997) Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss. Transplantation 64: 1493-1496.
14. Frohnert PF, Donadio JV Velosa JA, et al. (1997) The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 11: 127-133.
15. Kessler M, Hiesse C, Hestin D, et al. (1996) Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporin era. Am J Kidney Dis 28: 99-104.
16. Hartung R, Livingston B, Excell L, et al. (1995) Recurrence of IgA deposits/disease in grafts. An Australian Registry Survey 1980-1990. Contrib Nephrol 111: 13-17.
17. Odum J, Peh CA, Clarkson AR, et al. (1994) Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9: 309-312.
18. Bachman U, Biava C, Amend W, et al. (1986) The clinical course of IgA- nephropathy and Henoch-Schonlein purpura following renal transplantation. Transplantation 42: 511-515.
19. Lim EC, Chia D, Gjertson DW, et al. (1993) In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 55: 996-999.
20. McDonald SP, Russ GR. (2006) Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation 82: 759-762.
21. Suzuki K, Honda K, Tanabe K, et al. (2003) Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286-2294.
22. Ji S, Liu M, Chen J, et al. (2004) The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation. Clin Transplant 18: 536-540.
23. Mousson C, Charon-Barra C, Funes de la Vega M, et al. (2007) Recurrence of IgA nephropathy with crescents in kidney transplants. Transplant Proc 39: 2595-2596.
24. Kowalewska J, Yuan S, Sustento-Reodica N, et al. (2005) IgA nephropathy with crescents in kidney transplant recipients. Am J Kidney Dis 45: 167-175.
25. Oka K, Imai E, Moriyama T, et al. (2000) A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin- converting enzyme inhibitor. Nephrol Dial Transplant 15: 689-695.
26. Chandrakantan A, Ratanapanichkich P, Said M, et al. (2005) Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycohenolate mofetil. Nephrol Dial Transplant 20: 1214-1221.
27. Ibrahim H, Rogers T, Casingal V, et al. (2006) Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation 81: 214-219.
28. Calvino J, Lens XM, Romero R, et al. (2000) Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension. Nephrol Dial Transplant 15(1): 82-86.
29. Courtney AE, McNamee PT, Nelson WE, et al. (2006) Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy? Nephrol Dial Transplant 21: 3550-3554.
30. Barratt J, Feehally J. (2005) IgA nephropathy. J Am Soc Nephrol 16: 2088-2097.